Educational Program for Sexual Harassment
(E-STOP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment E-STOP in the Educational Program for Sexual Harassment?
The research on a training package for sexual harassment contact persons shows that such educational programs can effectively increase listening and helping skills, knowledge, and confidence, which are maintained over time. This suggests that similar educational treatments like E-STOP could be effective in addressing sexual harassment.12345
How is the E-STOP treatment for sexual harassment unique compared to other treatments?
The E-STOP treatment is unique because it focuses on an educational program that enhances listening and helping skills through a structured training package, which includes behavioral specifications, situational examples, and role-play exercises. This approach is different from other treatments as it emphasizes skill development and confidence building in handling sexual harassment situations, rather than just providing information or resources.16789
What is the purpose of this trial?
The study targets three aims: Aim 1: focuses on PIs' and mentors' confidence in their ability to intervene on sexual harassment and their attitudes, perceptions, and knowledge (APK) about sexual harassment, civility, microaggressions, and unconscious bias. Aim 2: focuses on trainees' experiences of sexual harassment and microaggressions and civility, sense of belonging, well-being, productivity, and persistence in a research career. Aim 3: focuses on the culture and climate of the research learning environment.
Research Team
Arghavan Salles
Principal Investigator
arghavan@stanford.edu
Eligibility Criteria
This trial is for Principal Investigators (PIs), mentors, and trainees involved in T-32 Programs. It aims to educate them on handling sexual harassment and improving the research environment. Those not associated with T-32 Programs cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants access online video modules through an online learning platform for up to 9 months
Post-Intervention Assessment
Initial post-survey for PIs and mentors shortly after the final module to evaluate short-term outcomes
Follow-up
Participants are monitored for long-term outcomes with surveys administered one and two years after intervention
Treatment Details
Interventions
- E-STOP
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator